| Dr Ann Catherine Vaughn, DC | |
|
25 Main St, Ste 337, Northampton, MA 01060-3109 | |
| (413) 585-8200 | |
| (413) 584-4335 |
| Full Name | Dr Ann Catherine Vaughn |
|---|---|
| Gender | Female |
| Speciality | Chiropractor - Sports Physician |
| Location | 25 Main St, Northampton, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073653267 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111NS0005X | Chiropractor - Sports Physician | 2231 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ann Catherine Vaughn, DC 25 Main St, Suite 337, Northampton, MA 01060-3109 Ph: (413) 585-8200 | Dr Ann Catherine Vaughn, DC 25 Main St, Ste 337, Northampton, MA 01060-3109 Ph: (413) 585-8200 |
News Archive
Agile Therapeutics, Inc., a pharmaceutical development company specializing in women's healthcare products, today announced the Company has completed patient enrollment in its pivotal, Phase 3 NEW CHOICE Study of AG200-15, Agile's lead contraceptive patch. Agile's NEW CHOICE Study enrolled 1500 women at over 100 sites throughout the U.S. The study is comparing the efficacy and tolerability of AG200-15 to a low-dose, oral contraceptive.
Older adults with long-term exposure to higher levels of pollution are at higher risk for hospitalization for pneumonia, according to researchers in Canada.
Gilead Sciences, Inc. announced today that it has refiled a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for the single-tablet regimen of Truvada® (emtricitabine and tenofovir disoproxil fumarate) and Tibotec Pharmaceuticals' investigational non-nucleoside reverse transcriptase inhibitor TMC278 (rilpivirine hydrochloride) for HIV-1 infection in adults.
For the past 70 years the treatment of choice for advanced, metastatic prostate cancer has been androgen-deprivation therapy. That is, the suppression of circulating testosterone - the hormone that fuels prostate-cancer growth - via surgical castration (orchiectomy) or medical castration with testosterone-blocking drugs. While such therapy buys time for patients, it is not a cure, as inevitably the cancer becomes resistant to the androgen deprivation and continues to grow.
› Verified 6 days ago
Richard W Kowalski, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 32 N Elm St, Northampton, MA 01060 Phone: 413-584-4209 Fax: 413-586-8595 | |
Mr. Josef Paul Arnould, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 241 King Street, Suite 123, Northampton, MA 01060 Phone: 413-586-4400 | |
Embodiment Institute Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 16 Center St, Suite 323, Northampton, MA 01060 Phone: 413-582-9111 Fax: 413-582-0333 | |
Timothy Molitoris, Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 32 Masonic St, Northampton, MA 01060 Phone: 413-570-0438 | |
Structure Enterprises Inc. Chiropractor Medicare: Medicare Enrolled Practice Location: 32 Masonic St, Northampton, MA 01060 Phone: 413-923-8035 | |
Bruce M Tutun, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 225r King St, Northampton, MA 01060 Phone: 413-584-0900 Fax: 413-584-2221 |